Cyclosporine monotherapy versus OKT3 an cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients : a multicenter randomized studyTransplantation proceedings. 1994, Vol 26, Num 5, pp 2522-2524, issn 0041-1345Conference Paper

Consensus statements on the optimal use of cyclosporine in pediatric patientsBRODEHL, J.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2759-2762, issn 0041-1345Conference Paper

Clinical immunosuppressive matrix in organ transplantationLAND, W.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2479-2484, issn 0041-1345Conference Paper

Impact of immunosuppressangs on host tissues and toleranceCALNE, R.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3065-3070, issn 0041-1345Conference Paper

Clinical algorithms for cyclosporine management based on pathophysiologic constructs of nephrotoxicityBENNETT, W. M.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2583-2584, issn 0041-1345Conference Paper

Impact of cyclosporine on chronic rejection and graft vasculopathyVANRENTERGHEM, Y; PEETERS, J.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2560-2563, issn 0041-1345Conference Paper

Optimal use of closporin A in liver transplantationMCMASTER, P; MIRZA, D. F.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2262-2664, issn 0041-1345Conference Paper

Toward quantitative theories of immunosuppressive drug action : averroes and the Arabic and Spanisch eras of medicineKAHAN, B. D.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2469-2474, issn 0041-1345Conference Paper

Effect of prophylactic gangiclovir on renal function and cyclosporine levels after heart transplantationCANTAROVICH, M; LATTER, D.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2747-2748, issn 0041-1345Conference Paper

Deoxyspergualin : a different and intriguing immunosuppressantTUFVESON, G; GANNEDAHL, G.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3029-3039, issn 0041-1345Conference Paper

Cyclosporine increases hepatocyte synthesis of the immunosuppressive free radical nitric oxideKUO, P. C.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2910-2911, issn 0041-1345Conference Paper

Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseasesBACH, J.-F.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3077-3081, issn 0041-1345Conference Paper

Cardiovascular effects of cyclosporine A and OG 37-325 after chronic administration to conscious rats : role of endothelinFOZARD, J. R; MENNINGER, K; SCHOEFFTER, P et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3006-3009, issn 0041-1345Conference Paper

FK 506 in solid organ transplantationFUNG, J. J; STARZL, T. E.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3017-3020, issn 0041-1345Conference Paper

Is there a relation between cycloporine trough levels and endomyocardial biopsy score after heart transplantation ?CANTATOVICH, M; LATTER, D; FITCHETT, D et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2725-2726, issn 0041-1345Conference Paper

Optimal immunosuppressive clinical regiman in liver transplantationFARGES, O; SAMUEL, D; BISMUTH, H et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2676-2678, issn 0041-1345Conference Paper

Userof sandimum neoral in renal transplant patientsFREI, U; TAESCH, S; NIESE, D et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2928-2931, issn 0041-1345Conference Paper

Controlled trials with cyclosporine in kidney transplantationPONTICELLI, C; TARANTINO, A; MONTAGNINO, G et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2490-2492, issn 0041-1345Conference Paper

Effect of graft inoculation with donor bone marrow cells on kidney allograft survival an antilymphocyte serum-treated reatsOTSU, I; GOTTSCHALK, R; MONACO, A. P et al.Transplantation proceedings. 1994, Vol 26, Num 5, issn 0041-1345, p. 3060Conference Paper

Comparison of pharmacokinetics between CsA capsules and sandimmun neoral in pediatric patientsLIN, C. Y; LEE, S. F.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2973-2974, issn 0041-1345Conference Paper

Efficacy of cyclosporine and angiosentin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the ratPAUL, L. C; DAVIDOFF, A; BENEDIKTSSON, H et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2873-2874, issn 0041-1345Conference Paper

Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administrationLAINE, J; HOPPU, K; HOLMBERG, C et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2775-2776, issn 0041-1345Conference Paper

The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell linesLANGMAN, L. J; YATSCOFF, R. W.Transplantation proceedings. 1994, Vol 26, Num 5, pp 3002-3005, issn 0041-1345Conference Paper

Use of two in vitro glomerular models to study the renal vasoreactivity of cyclosporineL'AZOU, B; LAKHDAR, B; CAMBAR, J et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2883-2885, issn 0041-1345Conference Paper

α/β, γ/δ T cells and interleukin-2 receptor chain expression in kidney graft recipients under triple-drug immunosuppressionZEZINA, L; KIRMAN, I; ROSENTAL, R et al.Transplantation proceedings. 1994, Vol 26, Num 5, issn 0041-1345, p. 2868Conference Paper